Study: Recovered COVID-19 patients likely have antibodies for at least 6 months
Researchers in the United Kingdom have found that most people who become infected with the coronavirus still have high levels of antibodies for at least six months after their recovery.
The study of 20,000 people was conducted by UK Biobank, with the results published on Wednesday. The scientists discovered that among subjects who previously tested positive for COVID-19, 99 percent had antibodies to SARS-CoV-2 three months after being infected, and after six months, 88 percent still had antibodies.
Naomi Allen, professor and chief scientist at UK Biobank, told reporters during a news conference that these numbers are consistent with findings from earlier studies carried out in the UK and Iceland. "Although we cannot be certain how this relates to immunity, the results suggest that people may be protected against subsequent infection for at least six months following natural infection," she said. "More prolonged follow-up will allow us to determine how long such protection is likely to last."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The study began last May, and UK Biobank found that the proportion of the population with COVID-19 antibodies rose from 6.6 percent at the start of the study to 8.8 percent by the end of the year.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Trump says 25% tariffs on Canada, Mexico start Feb. 1
Speed Read The tariffs imposed on America's neighbors could drive up US prices and invite retaliation
By Peter Weber, The Week US Published
-
Trump blames diversity, Democrats for DC air tragedy
Speed Read The president suggested that efforts to recruit more diverse air traffic controllers contributed to the deadly air crash
By Rafi Schwartz, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published